| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |